🇺🇸 FDA

Intelligence · Clinical Pipeline

Teva Pharma Pipeline

All ClinicalTrials.gov programs at Teva Pharma — phase, modality, and trial IDs.

Programs
473

Quick answer

Teva Pharma has 473 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Albuterol eMDPI DS

    Teva Pharma GmbH

    Asthma

    approved small molecule completed

    1 trial

  2. Albuterol-HFA-MDI

    Teva Pharma GmbH

    Asthma

    approved small molecule completed

    1 trial

  3. Alcohol Wipes vs. No Alcohol Wipes

    Teva Pharma GmbH

    Multiple Sclerosis

    approved other completed

    1 trial

  4. Alfacalcidol

    Teva Pharma GmbH

    Accidental Falls

    approved small molecule terminated

    1 trial

  5. Armodafinil

    Teva Pharma GmbH

    Menopause

    approved small molecule completed

    1 trial

  6. Armodafinil

    Teva Pharma GmbH

    Excessive Sleepiness

    approved small molecule completed

    3 trials

  7. Beclomethasone (QVAR)

    Teva Pharma GmbH

    Asthma

    approved small molecule completed

    1 trial

  8. Copaxone

    Teva Pharma GmbH

    Multiple Sclerosis

    approved small molecule completed

    2 trials

  9. Deutetrabenazine

    Teva Pharma GmbH

    Huntington's Disease

    approved small molecule completed

    1 trial

  10. Deutetrabenazine Oral Capsule

    Teva Pharma GmbH

    Tardive Dyskinesia

    approved small molecule active

    1 trial

  11. Digoxin

    Teva Pharma GmbH

    Heart Failure

    approved small molecule completed

    1 trial

  12. Fentanyl Buccal Tablet (FBT)

    Teva Pharma GmbH

    Cancer Pain

    approved small molecule terminated

    1 trial

  13. Fluticasone propionate/salmeterol (FS)

    Teva Pharma GmbH

    Asthma

    approved small molecule completed

    1 trial

  14. Fremanezumab

    Teva Pharma GmbH

    Migraine

    approved small molecule active

    9 trials

  15. Fremanezumab Prefilled Syringe [Ajovy]

    Teva Pharma GmbH

    Migraine Disorders

    approved small molecule terminated

    1 trial

  16. Glatiramer Acetate

    Teva Pharma GmbH

    Relapsing Remitting Multiple Sclerosis

    approved small molecule terminated

    5 trials

  17. Ketamine

    Teva Pharma GmbH

    Treatment Resistant Depression

    approved small molecule active

    1 trial

  18. Naproxen

    Teva Pharma GmbH

    Menorrhagia

    approved small molecule completed

    1 trial

  19. Qvar

    Teva Pharma GmbH

    Asthma

    approved small molecule terminated

    2 trials

  20. Qvar® (beclometasone dipropionate HFA)

    Teva Pharma GmbH

    Asthma

    approved small molecule completed

    1 trial

  21. Rasagiline

    Teva Pharma GmbH

    Sleep Disturbances

    approved small molecule completed

    1 trial

  22. Rasagiline

    Teva Pharma GmbH

    Parkinson's Disease

    approved small molecule active

    5 trials

  23. Rasagiline

    Teva Pharma GmbH

    Depressive Symptoms

    approved small molecule completed

    1 trial

  24. Rasagiline Mesylate

    Teva Pharma GmbH

    Parkinson's Disease

    approved small molecule completed

    8 trials

  25. Rasagiline/Placebo

    Teva Pharma GmbH

    Parkinson's Disease

    approved small molecule completed

    1 trial

  26. Reslizumab

    Teva Pharma GmbH

    Asthma

    approved small molecule active

    5 trials

  27. Reslizumab

    Teva Pharma GmbH

    Asthma; Eosinophilic

    approved mab completed

    1 trial

  28. SCE-B

    Teva Pharma GmbH

    Nocturnal Vasomotor Symptoms

    approved small molecule completed

    1 trial

  29. Shared Solutions® plus MS Center v. Shared Solutions®

    Teva Pharma GmbH

    Multiple Sclerosis

    approved other completed

    1 trial

  30. T-jet® containing TevTropin®

    Teva Pharma GmbH

    Growth Hormone Deficiency

    approved other completed

    1 trial

  31. armodafinil

    Teva Pharma GmbH

    Sleep Disorders

    approved small molecule completed

    1 trial

  32. diclofenac sodium topical gel

    Teva Pharma GmbH

    Multiple Sclerosis

    approved small molecule completed

    1 trial

  33. glatiramer acetate

    Teva Pharma GmbH

    Multiple Sclerosis

    approved small molecule active

    2 trials

  34. glatiramer acetate injection with oral cetirizine hydrochloride

    Teva Pharma GmbH

    Multiple Sclerosis

    approved small molecule completed

    1 trial

  35. mycophenolate mofetil (Myfenax)

    Teva Pharma GmbH

    Stable Renal Transplant Recipients

    approved small molecule terminated

    1 trial

  36. Albuterol eMDPI DS

    Teva Pharma GmbH

    Pulmonary Disease, Chronic Obstructive

    other completed

    1 trial

  37. Armodafinil

    Teva Pharma GmbH

    Sleep Apnea

    small molecule completed

    1 trial

  38. Azilect

    Teva Pharma GmbH

    Parkinson's Disease

    small molecule active

    1 trial

  39. Volcolon sugar free

    Teva Pharma GmbH

    Constipation

    small molecule completed

    1 trial

  40. extrafine HFA-beclomethasone

    Teva Pharma GmbH

    Asthma

    small molecule completed

    1 trial

  41. formoterol

    Teva Pharma GmbH

    Asthma

    small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does Teva Pharma have?

473 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.